| (INR) | Mar 2018 | Y/Y change |
|---|---|---|
| Revenue | 5.95B | — |
| Operating expense | — | — |
| Net income | 0.00 | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, NECLIFE.NS returned -32.5% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -44.8% |
| 1 year | -32.5% |
| 5 years | -64.9% |
| 10 years | -70.0% |
| All-time high | ₹54.15 (Dec 2015) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what ₹1,000 in NECLIFE.NS would be worth today ›No. Nectar Lifesciences Limited has not paid a dividend in the past 12 months.
Nectar Lifesciences Limited is part of the Healthcare sector.
Nectar Lifesciences Limited has a market cap of 2.08B INR, based on the latest quote.